KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scansource (SCSC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Scansource (SCSC) over the last 17 years, with Q4 2025 value amounting to $83.5 million.

  • Scansource's Cash & Equivalents fell 2447.88% to $83.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $83.5 million, marking a year-over-year decrease of 2447.88%. This contributed to the annual value of $126.2 million for FY2025, which is 3197.62% down from last year.
  • According to the latest figures from Q4 2025, Scansource's Cash & Equivalents is $83.5 million, which was down 2447.88% from $124.9 million recorded in Q3 2025.
  • Over the past 5 years, Scansource's Cash & Equivalents peaked at $185.5 million during Q2 2024, and registered a low of $34.1 million during Q4 2021.
  • For the 5-year period, Scansource's Cash & Equivalents averaged around $81.6 million, with its median value being $59.1 million (2021).
  • As far as peak fluctuations go, Scansource's Cash & Equivalents tumbled by 4921.19% in 2021, and later skyrocketed by 41263.2% in 2024.
  • Quarter analysis of 5 years shows Scansource's Cash & Equivalents stood at $34.1 million in 2021, then skyrocketed by 94.72% to $66.4 million in 2022, then plummeted by 32.29% to $45.0 million in 2023, then soared by 145.67% to $110.5 million in 2024, then decreased by 24.48% to $83.5 million in 2025.
  • Its Cash & Equivalents stands at $83.5 million for Q4 2025, versus $124.9 million for Q3 2025 and $126.2 million for Q2 2025.